immatics biotechnologies GmbH (4A3) — Net Asset Quality Index
immatics biotechnologies GmbH (4A3) has a Net Asset Quality Index of 86.1% as of December 2025. This metric measures the proportion of total assets financed by shareholders' equity — total assets of €562.34 Million minus total liabilities of €78.24 Million yields net assets of €484.10 Million. A higher index indicates a stronger, lower-leverage balance sheet. Check how resilient are immatics biotechnologies GmbH's assets to evaluate the company's liquid asset resilience ratio.
Quality Index
Net Assets
Total Assets
Total Liabilities
immatics biotechnologies GmbH Net Asset Quality Index Over Time (2019–2025)
This chart shows how immatics biotechnologies GmbH's Net Asset Quality Index has evolved across 7 annual periods from 2019 to 2025. As of December 2025, the index stands at 86.1%, representing net assets of €484.10 Million against total assets of €562.34 Million EUR. See immatics biotechnologies GmbH short-term liquidity ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Net Asset Quality Index for immatics biotechnologies GmbH (2019–2025)
The table below presents the year-by-year Net Asset Quality Index for immatics biotechnologies GmbH from 2019 to 2025, covering 7 annual filings. Each row shows total assets, total liabilities, net assets, the quality index percentage, and the change in percentage points compared to the prior year. For market capitalisation and the full company profile, see how much is immatics biotechnologies GmbH worth.
| Year | Quality Index | Net Assets (EUR) | Total Assets | Total Liabilities | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 86.1% | €484.10 Million | €562.34 Million | €78.24 Million | ▲ +3.5 pp |
| 2024 | 82.6% | €574.84 Million | €696.15 Million | €121.30 Million | ▲ +38.4 pp |
| 2023 | 44.1% | €225.08 Million | €509.96 Million | €284.88 Million | ▼ -8.1 pp |
| 2022 | 52.3% | €213.16 Million | €407.82 Million | €194.66 Million | ▲ +38.5 pp |
| 2021 | 13.8% | €24.06 Million | €174.65 Million | €150.58 Million | ▼ -27.2 pp |
| 2020 | 40.9% | €104.26 Million | €254.65 Million | €150.39 Million | ▲ +71.4 pp |
| 2019 | -30.4% | €-40.84 Million | €134.28 Million | €175.11 Million | — |